Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Case Report

Drug-induced liver injury caused by iodine-131

Chei Won Kim, Ji Sun Park, Se Hwan Oh, Jae-Hyung Park, Hyun-Ik Shim, Jae Woong Yoon, Jin Seok Park, Seong Bin Hong, Jun Mi Kim, Trong Binh Le, Jin Woo Lee

Clin Mol Hepatol. 2016;22(2):272-275. Published online May 20, 2016

DOI: https://doi.org/10.3350/cmh.2015.0037

View: 11519 Download: 147 Web of Science: 3 Crossref: 6

Liver Pathology

Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy

An Na Seo, Haeryoung Kim

Clin Mol Hepatol. 2014;20(1):81-84. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.81

View: 7603 Download: 101 Web of Science: 22 Crossref: 21

Review

Drug-induced liver injury: present and future

Ki Tae Suk, Dong Joon Kim

Clin Mol Hepatol. 2012;18(3):249-257. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.249

View: 18384 Download: 309 Crossref: 104

Original Article

The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis

Hye Young Ju, Jae Young Jang, Soung Won Jeong, Sung Ae Woo, Min Gyu Kong, Hee Yoon Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, So Young Jin, Hong Soo Kim, Boo Sung Kim

Clin Mol Hepatol. 2012;18(2):213-218. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.213

View: 9566 Download: 126 Crossref: 10

Case Report

A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage

Ju Seung Kim, Young Rock Jang, Ji Won Lee, Jin Yong Kim, Young Kul Jung, Dong Hae Chung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim

Clin Mol Hepatol. 2011;17(3):229-232. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.229

View: 9942 Download: 64 Crossref: 8

Review

Roles of X-box binding protein 1 in liver pathogenesis

Jihoon Tak, Yun Seok Kim, Sang Geon Kim

Received June 10, 2024 Accepted September 27, 2024

DOI: https://doi.org/10.3350/cmh.2024.0441 [Accepted]

View: 156 Download: 15

1 |

Viewed By 4873	MAFLD: How is it different from NAFLD?
Viewed By 4821	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 4665	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4401	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4341	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 214	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 155	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 133	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 117	MAFLD: How is it different from NAFLD?
Cited By 94	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search